Evidence map›Paper›PMID 40761870›Full record

ArticleFrontiers in medicine2025

DCAI: a dual cross-attention integration framework for benign-malignant classification of pulmonary nodules.

Shuling Wang, Suixue Wang, Rongdao Sun

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Shuling WangDepartment of Neurology, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.
Suixue WangSchool of Computer Science and Technology, Hainan University, Haikou, China.
Rongdao SunDepartment of Neurology, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer remains a leading cause of cancer-related mortality worldwide, and accurate early identification of malignant pulmonary nodules is critical for improving patient outcomes. Although artificial intelligence (AI) technology has shown promise in pulmonary nodule benign-malignant classification, existing methods struggle with modality heterogeneity and limited exploitation of complementary information across modalities. To address the above issues, we propose a novel multimodal framework, the Dual Cross-Attention Integration framework (DCAI), for benign-malignant classification of pulmonary nodules. Specifically, we first convert 3D nodules into multiple 2D images and obtain nodule features annotated by clinical experts. These features are encoded using Transformer models, and then a dual cross-attention module is proposed to dynamically align and interact with the complementary information between the different modalities. The fused representations from both modalities are then concatenated for benign-malignant prediction. We evaluate our proposed method on the LIDC-IDRI dataset, and experimental results demonstrate that DCAI outperforms several existing multimodal methods, highlighting the effectiveness of our approach in improving the accuracy of pulmonary nodule benign-malignant classification.

Indexed as

artificial intelligencebenign-malignant classificationcross-attentionmultimodalpulmonary noduletransformer

Identifiers

PMID40761870
PMCPMC12318739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.